Marcus M. Stroet
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Erratum: Defining the optimal imaging time point for fluorescence-lifetime-based tumor identification using the non-targeting near-infrared dye indocyanine green and post-processed high-dynamic-range images: errata.
Journal: Biomedical optics express
Published: May 06, 2026
In vivo Fluorescent Molecular Imaging Using Nanobodies Labeled with Next-Generation FNIR-Tag-Dyes.
Journal: Research square
Published: April 29, 2026
In vivo Fluorescent Molecular Imaging Using Nanobodies Labeled with Next-Generation FNIR-Tag-Dyes.
Journal: Molecular imaging and biology
Published: February 18, 2026
Defining the optimal imaging time point for fluorescence-lifetime-based tumor identification using the non-targeting near-infrared dye indocyanine green and post-processed high-dynamic-range images.
Journal: Biomedical optics express
Published: December 12, 2025
A Comparative Study on the Effect of Near-Infrared Fluorescent Dyes on the Pharmacokinetic Behavior of Nanobody-Based Tracers for In Vivo Imaging.
Journal: Journal of medicinal chemistry
Published: October 31, 2025
A Novel Luciferase-Based Reporter Gene Technology for Simultaneous Optical and Radionuclide Imaging of Cells.
Journal: International journal of molecular sciences
Published: June 13, 2024
The GEM-handle as convenient labeling strategy for bimodal single-domain antibody-based tracers carrying 99mTc and a near-infrared fluorescent dye for intra-operative decision-making.
Journal: Frontiers in immunology
Published: August 30, 2023
Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs.
Journal: Frontiers in pharmacology
Published: July 24, 2023
In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors.
Journal: Contrast media & molecular imaging
Published: October 15, 2021
Correction to: Evaluation of Ac-Lys0(IRDye800CW)Tyr3-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma.
Journal: Journal of neuro-oncology
Published: May 20, 2021
Last Updated: 09/26/2026